Sustainable nanomaterials for precision medicine in cancer therapy

dc.authorscopusidAli Zarrabi / 23483174100
dc.authorwosidAli Zarrabi / U-2602-2019
dc.contributor.authorBigham, Ashkan
dc.contributor.authorZarepour, Atefeh
dc.contributor.authorKhosravi, Arezoo
dc.contributor.authorIravani, Siavash
dc.contributor.authorZarrabi, Ali
dc.date.accessioned2025-04-18T10:31:44Z
dc.date.available2025-04-18T10:31:44Z
dc.date.issued2024
dc.departmentİstinye Üniversitesi, Mühendislik ve Doğa Bilimleri Fakültesi, Biyomedikal Mühendisliği Bölümü
dc.description.abstractSustainable nanomaterials have attracted much attention in the last decades in different applications mainly to minimize harm to environment by using renewable resources. One of those areas is precision medicine for cancer therapy, offering tailored solutions for targeted drug delivery, cancer immunotherapy, imaging/biosensing, and therapy monitoring. Recent trends in bio- and nanomedicine have focused on developing biocompatible and biodegradable multifunctional nanocarriers that enhance drug delivery efficiency while minimize systemic toxicity. Fabricating sustainable nanomaterials with smart functionalities, such as stimuli-responsive behavior and targeted drug release mechanisms, holds great potential for improving the efficacy of therapy with more desirable outcomes. However, challenges persist in ensuring the biosafety, targeting efficiency, and specificity of these nanomaterials; also, clinical translation studies, optimizing scalability, and cost-effectiveness in production processes need to be addressed. The primary purpose of this review is to examine the recent advancements in sustainable nanomaterials for precision medicine in targeted cancer therapy via summarizing the progress made in this field. In addition, we mentioned about the crucial challenges related to these innovative solutions, such as ensuring the safety and sustainability of nanomaterials. Moreover, by exploring the future perspectives of this technology, we hope to provide insights into the direction of developments in sustainable nanomaterials for precision medicine, particularly in the context of targeted cancer therapy.
dc.identifier.citationBigham, A., Zarepour, A., Khosravi, A., Iravani, S., & Zarrabi, A. (2024). Sustainable Nanomaterials for Precision Medicine in Cancer Therapy. Materials Today Sustainability, 100865.
dc.identifier.doi10.1016/j.mtsust.2024.100865
dc.identifier.endpage18
dc.identifier.issn2589-2347
dc.identifier.scopus2-s2.0-85194429938
dc.identifier.scopusqualityQ2
dc.identifier.startpage1
dc.identifier.urihttp://dx.doi.org/10.1016/j.mtsust.2024.100865
dc.identifier.urihttps://hdl.handle.net/20.500.12713/7105
dc.identifier.volume27
dc.identifier.wosWOS:001247994800001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorZarrabi, Ali
dc.institutionauthoridAli Zarrabi / 0000-0003-0391-1769
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofMaterials today sustainability
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectSustainable Nanomaterials
dc.subjectPrecision Medicine
dc.subjectTargeted Cancer Therapy
dc.subjectDrug Delivery
dc.subjectImmunotherapy
dc.subjectSustainability
dc.titleSustainable nanomaterials for precision medicine in cancer therapy
dc.typeArticle

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: